Drug reprofiling history and potential therapies against Parkinson’s disease

Drug reprofiling history and potential therapies against Parkinson’s disease

Given the high whittling down rates, high costs, and moderate pace of new medication, revelation, and improvement, repurposing “old” drugs to treat typical and uncommon illnesses is progressively becoming an appealing proposition. Drug repurposing is the way toward utilizing existing medications in...

Full description

Bibliographic Details
Main Authors:	Komal Latif, Aman Ullah, Anastasiia D. Shkodina, Dmytro I. Boiko, Zakia Rafique, Badrah S. Alghamdi, Mohamed A. Alfaleh, Ghulam Md. Ashraf
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Pharmacology
Subjects:	central nervous system drug repurposing Parkinson’s disease drug discovery neurodegeneration
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1028356/full

Similar Items

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors
by: Sunday N. Okafor, et al.
Published: (2023-08-01)

Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches
by: Ghulam Md. Ashraf, et al.
Published: (2022-07-01)

Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2021-11-01)

INFLUENCE OF SLEEP DISTURBANCES ON COGNITIVE DECLINE IN PATIENTS WITH PARKINSON’S DISEASE
by: Anastasiia Shkodina, et al.
Published: (2020-09-01)

Gold(I) ion and the phosphine ligand are necessary for the anti-Toxoplasma gondii activity of auranofin
by: C. I. Ma, et al.
Published: (2024-02-01)

Repurposing antifungal drugs for cancer therapy
by: Ningna Weng, et al.
Published: (2023-06-01)

Proof-of-Concept Preclinical Use of <i>Drosophila melanogaster</i> in the Initial Screening of Immunomodulators
by: Firzan Nainu, et al.
Published: (2022-02-01)

Advances in Antifungal Drug Development: An Up-To-Date Mini Review
by: Ghada Bouz, et al.
Published: (2021-12-01)

Machine-learning-based virtual screening and ligand docking identify potent HIV-1 protease inhibitors
by: Andrew K. Gao, et al.
Published: (2023-12-01)

Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis
by: Nicholas C. Poulton, et al.
Published: (2022-10-01)

Editorial: Artificial intelligence and machine learning for drug discovery, design and repurposing: methods and applications
by: Pan Zheng, et al.
Published: (2023-11-01)

Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment
by: Isha Karnik, et al.
Published: (2023-05-01)

Drug repurposing and prediction of multiple interaction types via graph embedding
by: E. Amiri Souri, et al.
Published: (2023-05-01)

Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
by: Agyemang Kwasi Sampene, et al.
Published: (2024-04-01)

Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
by: Trang T. T. Truong, et al.
Published: (2022-07-01)

Effective holistic characterization of small molecule effects using heterogeneous biological networks
by: William Mangione, et al.
Published: (2023-04-01)

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
by: Rajkumar Singh Kalra, et al.
Published: (2022-12-01)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
by: Mithun Rudrapal, et al.
Published: (2022-12-01)

Target-specific compound selectivity for multi-target drug discovery and repurposing
by: Tianduanyi Wang, et al.
Published: (2022-09-01)

Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
by: Eric Wen Su, et al.
Published: (2017-03-01)

Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
by: Smruti Sudha Nayak, et al.
Published: (2023-04-01)

Drug repurposing based on the similarity gene expression signatures to explore for potential indications of quercetin: a case study of multiple sclerosis
by: Yulong Chen, et al.
Published: (2023-09-01)

The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro, In Vivo, and In Silico Studies of Macromolecular Targets
by: Vinícius Roquini, et al.
Published: (2023-08-01)

An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
by: Luca Menestrina, et al.
Published: (2022-12-01)

Drosophila melanogaster as a Versatile Model for Studying Medically Important Insect Vector-Borne Parasites
by: Firzan Nainu, et al.
Published: (2022-06-01)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
by: Exequiel O. J. Porta, et al.
Published: (2023-07-01)

Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives
by: Wael Mohamed, et al.
Published: (2023-06-01)

A Surprising Repurposing of Central Nervous System Drugs against Squamous Cell Carcinoma of the Bladder, UM-UC-5
by: Maria João Gouveia, et al.
Published: (2024-01-01)

A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development
by: Jingyun Wu, et al.
Published: (2022-11-01)

Editorial: Translational neuroscience and reverse translational neuroscience: What's giving us hope?
by: Wael M. Y. Mohamed, et al.
Published: (2023-02-01)

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery
by: Anita Ioana Visan, et al.
Published: (2024-02-01)

In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
by: Calvin R. Wei, et al.
Published: (2024-01-01)

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
by: Liliana Rodrigues, et al.
Published: (2022-04-01)

Updates on drug designing approach through computational strategies: a review
by: Iqbal Azad, et al.
Published: (2023-06-01)

Pharmaceutical patent landscaping: A novel approach to understand patents from the drug discovery perspective
by: Yojana Gadiya, et al.
Published: (2023-12-01)

Empowering the discovery of novel target-disease associations via machine learning approaches in the open targets platform
by: Yingnan Han, et al.
Published: (2022-06-01)

Applications and prospects of cryo-EM in drug discovery
by: Kong-Fu Zhu, et al.
Published: (2023-03-01)

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
by: Mario Roberto Senger, et al.

The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
by: Emily Sun, et al.
Published: (2022-08-01)